NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/23/2024
Back to search
Official data from USPTO
SCHEDULE 1 THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SCHEDULE 1 THERAPEUTICS
ST13
US500000090613244Class
42, 44
Filing
90613244
Registration
7289223
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
01/23/2024
Trademark type
Word
Nice classes
42, 44
Filing date
03/30/2021
Registration date
01/23/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/23/2024
Last transaction
01/23/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
12/20/2018
First use in commerce
12/20/2018
Drawing code
4
Owner type
03
Owner location
Chicago, IL
Examiner
LOBO, DEBORAH
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Schedule 1 Therapeutics, Inc.
Representatives
Hillary E. Maynard POLSINELLI PC
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Providing medical and scientific research in the field of pharmaceuticals; providing medical and scientific research in field of cannabis and cannabis-based medicines; providing medical and scientific research in the field of migraine treatment; all of the foregoing services involving hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; providing medical and scientific research information in the field of clinical trials; providing information about medical research
Class 44
providing information in the field of pharmaceuticals; providing information in the field of migraines; providing information about the health benefits of cannabis; providing medical information in the field of cannabis; providing information about the treatment of migraines; providing information about cannabis-based medicines; providing health information; providing information about the treatment of migraines in connection with cannabis-based medicines; providing medical information; providing medical information via a website
Publications
History of USPTO decisions and trademark events.
37 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
01/23/2024
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
09/20/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
09/20/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/20/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
09/20/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/20/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/20/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/19/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/19/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/14/2023
GNRT
NON-FINAL ACTION E-MAILED
07/14/2023
CNRT
NON-FINAL ACTION WRITTEN
07/14/2023
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
07/14/2023
IUAA
USE AMENDMENT ACCEPTED
07/13/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/24/2023
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
05/23/2023
IUAF
USE AMENDMENT FILED
05/23/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/22/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/22/2023
EAAU
TEAS AMENDMENT OF USE RECEIVED
05/22/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/22/2022
GNRT
NON-FINAL ACTION E-MAILED
11/22/2022
CNRT
NON-FINAL ACTION WRITTEN
11/22/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/19/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/19/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/19/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/18/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
10/18/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/18/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/18/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/29/2022
GNRT
NON-FINAL ACTION E-MAILED
04/29/2022
CNRT
NON-FINAL ACTION WRITTEN
04/29/2022
DOCK
ASSIGNED TO EXAMINER
04/25/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/07/2021
NWAP
NEW APPLICATION ENTERED
04/02/2021
Continuous trademark protection
Get notified about every new filing that threatens SCHEDULE 1 THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.